Trial Profile
A first-in-humans study investigating the effect of E1E2/MF59C.1 vaccine in healthy subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs HCV E1E2MF59 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2010 New trial record.